MYD88 and Hepatic steatosis: The results of this study showed that it inhibited p65 nuclear translocation and NF-θB DNA-binding activity and that it decreased the expression of myeloid differentiation factor 88 (MyD88) in the liver, which, in turn, decreased hepatic steatosis [108].